Julio Wainstein

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

High Caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women

Daniela Jakubowicz, Maayan Barnea, Julio Wainstein et al. · Obesity · 2013 · 569 citations · Full text

Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood

Gidon Toperoff, Dvir Aran, Jeremy D. Kark et al. · Human Molecular Genetics · 2011 · 353 citations · Full text

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9